Trade Summary

4 days ago, Cvijic Christine Mikail, serving as President and CFO at Neurogene Inc. (NGNE), sold 4,800 shares at $36.12 per share, for a total transaction value of $173,375.40. Following this transaction, Cvijic Christine Mikail now holds 84,040 shares of NGNE.

This sale represents a 5.40% decrease in Cvijic Christine Mikail's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, July 6, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 8, 2026 (accepted Jul 7, 9:08 PM ET), 2 days after the trade was made.

Neurogene Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.